{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:42:46Z","timestamp":1790379766664,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-070"],"award-info":[{"award-number":["2022-PUMCH-B-070"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-071"],"award-info":[{"award-number":["2022-PUMCH-B-071"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["CIFMS2021-I2M-C&T-B-006"],"award-info":[{"award-number":["CIFMS2021-I2M-C&T-B-006"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Crohn disease is a chronic granulomatous inflammatory disease of gastrointestinal tract. Previous studies showed Crohn disease strictures overexpress fibroblast activation protein and had active\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 uptake. Our study was to compare the diagnostic performance of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 and\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in Crohn disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>\n                      This is a prospective cohort study recruiting patients with newly diagnosed or relapsed Crohn disease. All the patients underwent\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 and\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT. The diagnostic performance of the 2 PET\/CT modalities and their uptake values were compared. The correlation of PET semiquantitative parameters [metabolic intestinal volume (MIV\n                      <jats:sub>FDG<\/jats:sub>\n                      and MIV\n                      <jats:sub>FAPI<\/jats:sub>\n                      ), total intestinal uptake (TIU\n                      <jats:sub>FDG<\/jats:sub>\n                      and TIU\n                      <jats:sub>FAPI<\/jats:sub>\n                      )] with clinical biomarkers were also analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Seventeen participants (13 men and 4 women, age 32.3 \u00b1 15.9 y) were recruited. The sensitivity of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 and\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in detecting Crohn lesions were 90.0% and 85.0%, and the specificities were 93.0% and 88.4%, respectively. In receiver operating characteristic curve analysis,\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 PET\/CT [area under the curve = 0.92 (95% CI: 0.83\u20130.97),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001] showed better diagnostic performance compared with\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT [area under the curve = 0.87 (95% CI: 0.78\u20130.93),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.043]. The SUVmax of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI and\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG in stricture\/fistula lesions were significantly higher than those in non-stricture\/fistula lesions (\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI, 10.9 \u00b1 6.7 vs 5.0 \u00b1 3.5,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0002;\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG, 9.5 \u00b1 4.9 vs 5.3 \u00b1 1.8,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0016). TIU\n                      <jats:sub>FAPI<\/jats:sub>\n                      and MIV\n                      <jats:sub>FAPI<\/jats:sub>\n                      of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 PET\/CT were significantly correlated with high sensitivity C-reactive protein and simple endoscopic score for Crohn disease (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). TIU\n                      <jats:sub>FDG<\/jats:sub>\n                      and MIV\n                      <jats:sub>FDG<\/jats:sub>\n                      of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT were also correlated with simple endoscopic scores for Crohn disease (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      Ga-FAPI-04 PET\/CT showed better diagnostic performance than\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in Crohn disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005815","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T19:27:38Z","timestamp":1743708458000},"page":"473-479","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Head-to-Head Comparison of 68Ga-FAPI-04 and 18F-FDG PET\/CT for the Assessment of Crohn\u2019s Disease"],"prefix":"10.1097","volume":"50","author":[{"given":"Qingqing","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital"},{"name":"State Key Laboratory of Common Mechanism Research for Major Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8459-7654","authenticated-orcid":false,"given":"Hui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Dongcheng, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3626-0217","authenticated-orcid":false,"given":"Silu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital"},{"name":"State Key Laboratory of Common Mechanism Research for Major Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-8611","authenticated-orcid":false,"given":"Hongzhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital"},{"name":"State Key Laboratory of Common Mechanism Research for Major Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Dongcheng, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Dongcheng, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital"},{"name":"State Key Laboratory of Common Mechanism Research for Major Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-1136","authenticated-orcid":false,"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital"},{"name":"State Key Laboratory of Common Mechanism Research for Major Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"R1-20250613","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.semnuclmed.2023.10.005","article-title":"PET\/CT in inflammatory and auto-immune disorders: focus on several key molecular concepts, FDG, and radiolabeled probe perspectives","volume":"54","author":"Besson","year":"2024","journal-title":"Semin Nucl Med"},{"key":"R2-20250613","first-page":"1522","article-title":"Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG","volume":"46","author":"Pellegrino","year":"2005","journal-title":"J Nucl Med"},{"key":"R3-20250613","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00003072-200110000-00015","article-title":"F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease","volume":"26","author":"Kresnik","year":"2001","journal-title":"Clin Nucl Med"},{"key":"R4-20250613","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2967\/jnumed.107.040436","article-title":"Noninvasive assessment of Crohn\u2019s disease intestinal lesions with (18)F-FDG PET\/CT","volume":"48","author":"Louis","year":"2007","journal-title":"J Nucl Med"},{"key":"R5-20250613","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1007\/s10620-012-2190-8","article-title":"18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn\u2019s disease","volume":"57","author":"Holtmann","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R6-20250613","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-023-06107-5","article-title":"[(68)Ga]Ga-FAPI-04 PET\/CT on assessing Crohn\u2019s disease intestinal lesions","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20250613","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1097\/RLU.0000000000005379","article-title":"Comparing the diagnostic value of FDG PET or PET\/CT with FDG PET\/MR in inflammatory bowel disease\u2014a systematic review and meta-analysis","volume":"49","author":"Lin","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20250613","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.semnuclmed.2021.04.001","article-title":"Variants and pitfalls in PET\/CT imaging of gastrointestinal cancers","volume":"51","author":"Jayaprakasam","year":"2021","journal-title":"Semin Nucl Med"},{"key":"R9-20250613","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","article-title":"Long-term evolution of disease behavior of Crohn\u2019s disease","volume":"8","author":"Cosnes","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"R10-20250613","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ecco-jcc\/jjw055","article-title":"European Crohn\u2019s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn\u2019s disease","volume":"10","author":"Rieder","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/2050640616640160","article-title":"Biomarkers of intestinal fibrosis\u2014one step towards clinical trials for stricturing inflammatory bowel disease","volume":"4","author":"Giuffrida","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"R12-20250613","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2008.10.008","article-title":"Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn\u2019s disease","volume":"7","author":"Sampietro","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R13-20250613","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ibd.21446","article-title":"Fibroblast activation protein expression in Crohn\u2019s disease strictures","volume":"17","author":"Rovedatti","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R14-20250613","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ibd\/izx008","article-title":"Inhibition of fibroblast activation protein restores a balanced extracellular matrix and reduces fibrosis in Crohn\u2019s disease strictures ex vivo","volume":"24","author":"Truffi","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R15-20250613","doi-asserted-by":"crossref","first-page":"222389","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of intestinal fibrosis with (68)Ga-FAPI PET\/MR enterography in Crohn disease","volume":"307","author":"Scharitzer","year":"2023","journal-title":"Radiology"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R17-20250613","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","article-title":"A comprehensive review and update on Crohn\u2019s disease","volume":"64","author":"Gajendran","year":"2018","journal-title":"Dis Mon"},{"key":"R18-20250613","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0140-6736(80)91372-0","article-title":"Simple index of Crohn\u2019s disease activity","volume":"1","author":"Elliott","year":"1980","journal-title":"Lancet"},{"key":"R19-20250613","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R20-20250613","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein-targeted PET\/CT with (68)Ga-FAPI for imaging IgG4-related disease: comparison to (18)F-FDG PET\/CT","volume":"62","author":"Luo","year":"2021","journal-title":"J Nucl Med"},{"key":"R21-20250613","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"Annese","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R22-20250613","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-991027","article-title":"Perianal Crohn\u2019s disease","volume":"20","author":"Safar","year":"2007","journal-title":"Clin Colon Rectal Surg"},{"key":"R23-20250613","doi-asserted-by":"crossref","first-page":"20220463","DOI":"10.1259\/bjr.20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/CT imaging","volume":"96","author":"Hotta","year":"2023","journal-title":"Br J Radiol"},{"key":"R24-20250613","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00259-024-06644-7","article-title":"Comparative analysis of [(18)F]F-FAPI PET\/CT, [(18)F]F-FDG PET\/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn\u2019s disease: a prospective animal model and human cohort study","volume":"51","author":"Li","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-20250613","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cgh.2006.02.003","article-title":"Diagnostic value of C-reactive protein for predicting activity level of Crohn\u2019s disease","volume":"4","author":"Chamouard","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-20250613","first-page":"e59009","article-title":"C-reactive protein: an inflammatory biomarker and a predictor of neurodegenerative disease in patients with inflammatory bowel disease?","volume":"16","author":"Muresan","year":"2024","journal-title":"Cureus"},{"key":"R27-20250613","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S2468-1253(17)30212-1","article-title":"Beyond disease activity to overall disease severity in inflammatory bowel disease","volume":"2","author":"Koliani-Pace","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R28-20250613","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cgh.2015.06.001","article-title":"Defining disease severity in inflammatory bowel diseases: current and future directions","volume":"14","author":"Peyrin-Biroulet","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-20250613","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2967\/jnumed.112.112623","article-title":"Translational 18F-FDG PET\/CT imaging to monitor lesion activity in intestinal inflammation","volume":"54","author":"Bettenworth","year":"2013","journal-title":"J Nucl Med"},{"key":"R30-20250613","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/17474124.2020.1732817","article-title":"Anemia and iron deficiency in Crohn\u2019s disease","volume":"14","author":"Yueying","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000005815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:58:24Z","timestamp":1786035504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000005815"}},"subtitle":["A Prospective Pilot Study"],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005815","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"2024-08-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}